Policy & governance of innovative technologies

Regulations, standards and guidelines to ensure safety, quality and efficacy are an integral part of the development of technological advances, particularly in life sciences. Innogen’s research on the governance systems we adopt for innovative technologies, how such choices are made and their impact on future innovation trajectories, the fate of future sectors of the economy, and the competitive advantage of nations, is internationally unique.

Projects

Better politics for biotechnological innovations

9 September 2021

In a Commentary piece published in Transgenic Research, Alan Raybould, Innogen member and Chair in Innovation in the Life Sciences at the University of Edinburgh, argues that political leaders need to make a stronger case for green biotechnology in achieving food security and other sustainable development goals.

In Conversation event: Unlocking genetic technologies for agriculture

10 March 2022

On the 23rd of February, Peter Kearns, Special Advisor to Re-Imagine Europa, Joyce Tait, and Alan Raybould discussed the current regulation of genetic technologies for agriculture in the UK, Europe and the rest of the world.

Is ‘Plan B’ on the Horizon?

27 October 2022

As the UK’s ‘Plan B’ alternative to association with Horizon Europe looks ever more likely, will it be any better in supporting UK business innovation?

Innogen Alumni, a blog post by Dave Wield

2 June 2025

If you are an Innogen Alumnus, or even if you are not, why don’t you check in and let us know what you are up to right now.

Synbio in the UK – A decade of developments

19 September 2019

The Synthetic Biology Leadership Council (SBLC) has published an overview of UK synbio activities in the last decade.